Literature DB >> 23117947

Idiopathic inflammatory myopathies.

Mazen M Dimachkie1, Richard J Barohn.   

Abstract

The idiopathic inflammatory myopathies are a group of rare disorders including polymyositis (PM), dermatomyositis (DM), and autoimmune necrotizing myopathies (NMs). The idiopathic inflammatory myopathies share many similarities. They present acutely, subacutely, or chronically with marked proximal and symmetric muscle weakness, except for associated distal and asymmetric weakness in inclusion body myositis. The idiopathic inflammatory myopathies also share a variable degree of creatine kinase (CK) elevation and a nonspecifically abnormal electromyogram demonstrating an irritative myopathy. The muscle pathology demonstrates inflammatory exudates of variable distribution within the muscle fascicle. Despite these similarities, the idiopathic inflammatory myopathies are a heterogeneous group. The overlap syndrome (OS) refers to the association of PM, DM, or NM with connective tissue disease, such as scleroderma or systemic lupus erythematosus. In addition to elevated antinuclear antibodies (ANA), patients with OS may be weaker in the proximal arms than the legs mimicking the pattern seen in some muscular dystrophies. In this review, we focus on DM, PM, and NM and examine current and promising therapies. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23117947      PMCID: PMC3534736          DOI: 10.1055/s-0032-1329201

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  95 in total

1.  Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis.

Authors:  F W Miller; S F Leitman; M E Cronin; J E Hicks; R L Leff; R Wesley; D D Fraser; M Dalakas; P H Plotz
Journal:  N Engl J Med       Date:  1992-05-21       Impact factor: 91.245

2.  Myeloid dendritic cells in inclusion-body myositis and polymyositis.

Authors:  Steven A Greenberg; Geraldine S Pinkus; Anthony A Amato; Jack L Pinkus
Journal:  Muscle Nerve       Date:  2007-01       Impact factor: 3.217

3.  Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.

Authors:  Ronan J Walsh; Sek Won Kong; Yihong Yao; Bahija Jallal; Peter A Kiener; Jack L Pinkus; Alan H Beggs; Anthony A Amato; Steven A Greenberg
Journal:  Arthritis Rheum       Date:  2007-11

4.  Combined steroid, methotrexate and chlorambucil therapy for steroid-resistant dermatomyositis.

Authors:  M Cagnoli; A Marchesoni; S Tosi
Journal:  Clin Exp Rheumatol       Date:  1991 Nov-Dec       Impact factor: 4.473

5.  Progressive myopathy with up-regulation of MHC-I associated with statin therapy.

Authors:  Merrilee Needham; Victoria Fabian; Wally Knezevic; Peter Panegyres; Paul Zilko; Frank L Mastaglia
Journal:  Neuromuscul Disord       Date:  2007-01-22       Impact factor: 4.296

6.  Long-term outcome in polymyositis and dermatomyositis.

Authors:  I M Bronner; M F G van der Meulen; M de Visser; S Kalmijn; W J van Venrooij; A E Voskuyl; H J Dinant; W H J P Linssen; J H J Wokke; J E Hoogendijk
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

7.  Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.

Authors:  Nizar Chahin; Andrew G Engel
Journal:  Neurology       Date:  2007-09-19       Impact factor: 9.910

8.  Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy.

Authors:  M M Joffe; L A Love; R L Leff; D D Fraser; I N Targoff; J E Hicks; P H Plotz; F W Miller
Journal:  Am J Med       Date:  1993-04       Impact factor: 4.965

Review 9.  Exercise effects in patients with adult idiopathic inflammatory myopathies.

Authors:  Helene Alexanderson
Journal:  Curr Opin Rheumatol       Date:  2009-03       Impact factor: 5.006

10.  Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial.

Authors:  Yuen-Li Chung; Helene Alexanderson; Nicoló Pipitone; Catherine Morrison; Maryam Dastmalchi; Christina Ståhl-Hallengren; Selwyn Richards; E Louise Thomas; Gavin Hamilton; Jimmy D Bell; Ingrid E Lundberg; David L Scott
Journal:  Arthritis Rheum       Date:  2007-05-15
View more
  11 in total

Review 1.  The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.

Authors:  Ilaria Cavazzana; Micaela Fredi; Carlo Selmi; Angela Tincani; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 2.  Stem cell therapy in autoimmune rheumatic diseases: a comprehensive review.

Authors:  Bin Liu; ShangAn Shu; Thomas P Kenny; Christopher Chang; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 3.  Toxic myopathies.

Authors:  Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

Review 4.  [Paraneoplastic neurological syndromes and autoimmune encephalitis].

Authors:  O Stich; S Rauer
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

5.  Kennedy disease misdiagnosed as polymyositis: a case report.

Authors:  Grigor M Harutunian; Said R Beydoun; Richard A Rison
Journal:  BMC Res Notes       Date:  2013-09-28

Review 6.  Idiopathic Inflammatory Myopathies: Clinical Approach and Management.

Authors:  Asma Malik; Ghazala Hayat; Junaid S Kalia; Miguel A Guzman
Journal:  Front Neurol       Date:  2016-05-20       Impact factor: 4.003

7.  Paraneoplastic Dermatomyositis Syndrome Presenting as Dysphagia.

Authors:  Emmanuel Ofori; Daryl Ramai; Mel Ona; Madhavi Reddy
Journal:  Gastroenterology Res       Date:  2017-08-31

8.  The effect of a 24-week training focused on activities of daily living, muscle strengthening, and stability in idiopathic inflammatory myopathies: a monocentric controlled study with follow-up.

Authors:  Maja Špiritović; Barbora Heřmánková; Sabína Oreská; Hana Štorkánová; Olga Růžičková; Lucia Vernerová; Martin Klein; Kateřina Kubínová; Hana Šmucrová; Adéla Rathouská; Petr Česák; Martin Komarc; Václav Bunc; Karel Pavelka; Ladislav Šenolt; Heřman Mann; Jiří Vencovský; Michal Tomčík
Journal:  Arthritis Res Ther       Date:  2021-06-21       Impact factor: 5.156

9.  Effect of butylphthalide intervention on experimental autoimmune myositis in guinea pigs.

Authors:  Juan Chen; Jingyang Wang; Jiyan Zhang; Chuanqiang Pu
Journal:  Exp Ther Med       Date:  2017-11-01       Impact factor: 2.447

10.  A Rare Case of Necrotizing Myopathy and Fibrinous and Organizing Pneumonia with Anti-EJ Antisynthetase Syndrome and SSA Antibodies.

Authors:  Muhammad Kashif; Divya Arya; Masooma Niazi; Misbahuddin Khaja
Journal:  Am J Case Rep       Date:  2017-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.